Regulatory challenges for refined nicotine products

被引：5

作者：

Cobb, Nathan K. ^{[1
,2
,3
,4
]}

Cobb, Caroline O. ^{[4
]}

机构：

[1] Georgetown Univ, Med Ctr, Dept Pulm & Crit Care, Washington, DC 20007 USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA

[3] MeYou Hlth LLC, Boston, MA USA

[4] Amer Legacy Fdn, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA

来源：

LANCET RESPIRATORY MEDICINE | 2013年 / 1卷 / 06期

关键词：

ELECTRONIC CIGARETTES; DELIVERY;

D O I：

10.1016/S2213-2600(13)70160-7

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：431 / 433

页数：4

共 10 条

[1]

Burritt C, 2013, ALTRIA SELL E CIGAEE

[2] E-Cigarette or Drug-Delivery Device? Regulating Novel Nicotine Products [J].

Cobb, Nathan K. ;

Abrams, David B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (03) :193-195

[3] Nicotine Levels in Electronic Cigarettes [J].

Goniewicz, Maciej L. ;

Kuma, Tomasz ;

Gawron, Michal ;

Knysak, Jakub ;

Kosmider, Leon .

NICOTINE & TOBACCO RESEARCH, 2013, 15 (01) :158-166

[4]

Herzog, 2013, TOBACCO NIELSEN C ST

[5] Reducing harm from tobacco use [J].

McNeill, Ann ;

Munafo, Marcus R. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (01) :13-18

[6] Pulmonary Delivery of Nicotine Pyruvate: Sensory and Pharmacokinetic Characteristics [J].

Rose, Jed E. ;

Turner, James E. ;

Murugesan, Thangaraju ;

Behm, Frederique M. ;

Laugesen, Murray .

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2010, 18 (05) :385-394

[7]

US Food and Drug Administration, 2013, FDA 101 SMOK CESS PR

[8] Clinical laboratory assessment of the abuse liability of an electronic cigarette [J].

Vansickel, Andrea R. ;

Weaver, Michael F. ;

Eissenberg, Thomas .

ADDICTION, 2012, 107 (08) :1493-1500

[9] Electronic Cigarettes: Effective Nicotine Delivery After Acute Administration [J].

Vansickel, Andrea Rae ;

Eissenberg, Thomas .

NICOTINE & TOBACCO RESEARCH, 2013, 15 (01) :267-270

[10]

Woodcock J., 2011, COMMUNICATION

← 1 →